With the analysis among 49 patents, we discovered top 41 key players by total patent application. Bristol Myers Squibb Co., Bristol Myers Co., NCPC Hebei Huamin Pharmaceutical Co. Ltd. are dominant in this area. They take 24.49% of the total patent filing.
New York, United States
Patent: 6
New York, United States
Patent: 4
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
Hebei Sheng, China
Patent: 2
Hainan Herui Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co. Ltd.
Guangdong Sheng, China
Patent: 2
Jiangsu Hanstone Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Hainan Lingkang Pharmaceutical Co., Ltd.
Hainan Sheng, China
Patent: 2
New York, United States
Patent: 1
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 1
Hovedstaden, Denmark
Patent: 1
No data, please try another search term
With the analysis among related 6 patents applied in the last 5 years. We discover 4 most active companies in this area. The fast-growing NCPC Hebei Huamin Pharmaceutical Co. Ltd., Jiangsu Hanstone Pharmaceutical Co., Ltd., Hainan General Sanyang Pharmaceutical Co. Ltd. take 83.33% of patent filing during this period.
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
Hebei Sheng, China
Patent: 2
Jiangsu Hanstone Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Hainan General Sanyang Pharmaceutical Co. Ltd.
Hainan Sheng, China
Patent: 1
Dawnrays (Nantong) Pharmaceutical Science & Technology Co.,
Jiangsu Sheng, China
Patent: 1
With the analysis among related 6 patents in last 5 years, we discover 4 new entrants. NCPC Hebei Huamin Pharmaceutical Co. Ltd., Jiangsu Hanstone Pharmaceutical Co., Ltd., Hainan General Sanyang Pharmaceutical Co. Ltd. are the most active new entrants in this area.
NCPC Hebei Huamin Pharmaceutical Co. Ltd.
Hebei Sheng, China
Patent: 2
Jiangsu Hanstone Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Hainan General Sanyang Pharmaceutical Co. Ltd.
Hainan Sheng, China
Patent: 1
Dawnrays (Nantong) Pharmaceutical Science & Technology Co.,
Jiangsu Sheng, China
Patent: 1
No data, please try another search term